Ken Griffin X Biotech Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $6,045 - $12,195	1,500 Added 750.0%	1,700 $13,000
Q4 2023 Feb 14, 2024	SELL	$3.56 - $4.65 $18,512 - $24,180	-5,200 Reduced 96.3%	200 $0
Q3 2023 Nov 14, 2023	BUY	$4.02 - $5.81 $803 - $1,162	200 Added 3.85%	5,400 $22,000
Q2 2023 Aug 14, 2023	SELL	$3.06 - $6.38 $17,136 - $35,728	-5,600 Reduced 51.85%	5,200 $30,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.72 $34,776 - $50,976	10,800 New	10,800 $37,000

3.96M

6.3K

1.7K

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $156M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.